Predominant 3/4R tau isoforms of patients with AD patients comprise favorable energetic and kinetic properties with regard to [18F]PI-2620 binding, compared to predominant 4 R tau isoforms of primary tauopathies [79]. Here, MAPT is linked to Alzheimer disease.